1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura
1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura structure
|
Common Name | 1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura | ||
|---|---|---|---|---|
| CAS Number | 34840-23-8 | Molecular Weight | 206.220 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C6H10N2O4S | Melting Point | 102-105ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Melting Point | 102-105ºC(lit.) |
| Molecular Formula | C6H10N2O4S |
| Molecular Weight | 206.220 |
| Exact Mass | 206.036133 |
| PSA | 102.29000 |
| LogP | 1.03 |
| Index of Refraction | 1.520 |
|
~71%
1,3-Bis(methoxy... CAS#:34840-23-8 |
| Literature: BioCryst Pharmaceuticals, Inc. Patent: US2004/254181 A1, 2004 ; Location in patent: Page 16 ; |
|
~45%
1,3-Bis(methoxy... CAS#:34840-23-8 |
| Literature: Fonseca, Tatiana; Gigante, Barbara; Marques, M. Matilde; Gilchrist, Thomas L.; De Clercq, Erik Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 1 p. 103 - 112 |
|
~%
1,3-Bis(methoxy... CAS#:34840-23-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 32, # 2 p. 409 - 417 |
|
~%
1,3-Bis(methoxy... CAS#:34840-23-8 |
| Literature: Tetrahedron, , vol. 51, # 39 p. 10771 - 10794 |
| Precursor 5 | |
|---|---|
| DownStream 10 | |
CAS#:58306-30-2
CAS#:22769-68-2
CAS#:54965-21-8![4H-Pyrrolo[3,2-d]pyrimidin-4-one,2-amino-3,5-dihydro- structure](https://image.chemsrc.com/caspic/137/65996-58-9.png)
CAS#:65996-58-9
CAS#:54029-12-8
CAS#:615-16-7![5-Chloro-1H-benzo[d]imidazol-2(3H)-one structure](https://image.chemsrc.com/caspic/301/2034-23-3.png)
CAS#:2034-23-3![dimethyl 4-[2-(methoxycarbonylamino)-3H-benzimidazol-5-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate structure](https://image.chemsrc.com/caspic/442/121497-18-5.png)
CAS#:121497-18-5![2-((Methoxycarbonyl)amino)-1H-benzo[d]imidazole-5-carboxylic acid structure](https://image.chemsrc.com/caspic/337/65003-40-9.png)
CAS#:65003-40-9
CAS#:69810-99-7|
CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.
Antimicrob. Agents Chemother. 57(11) , 5448-56, (2013) Albendazole and fenbendazole are broad-spectrum anthelmintics that undergo extensive metabolism to form hydroxyl and sulfoxide metabolites. Although CYP3A and flavin-containing monooxygenase have been... |
|
|
Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo [3, 2-d] pyrimidines as dual thymidylate synthase and dihydrofolate Gangjee A, et al.
J. Med. Chem. 51(1) , 68-76, (2007)
|
| 1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudoeura |
| 2-Methylisothiourea-1,3-dicarboxylate |
| Carbamic acid, N,N'-[(methylthio)methylidyne]bis-, dimethyl ester |
| Dimethyl [(E)-(methylthio)methylylidene]biscarbamate |
| Dimethyl [(E)-(methylsulfanyl)methylylidene]biscarbamate |
| MFCD00674104 |
| carbamic acid, N,N'-[(Z)-(methylthio)methylidyne]bis-, dimethyl ester |
| Dimethyl [(methylsulfanyl)methylylidene]biscarbamate |
| Dimethyl [(Z)-(methylsulfanyl)methylylidene]biscarbamate |
| carbamic acid, N,N'-[(E)-(methylthio)methylidyne]bis-, dimethyl ester |
| EINECS 252-240-2 |